Individual Patient Compassionate Use of GX-I7

Genexine

Status

Conditions: Advanced Cancer; Glioblastoma; Melanoma; Recurrent Glioblastoma; High Grade Glioma

Treatments: Drug: GX-I7

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT04289155

GX-I7_TP

Details and patient eligibility

About

Compassionate use of GX-I7 for patients with serious life-threatening illness that have exhausted all available therapies, with no other therapy options.

Full description

This program is being offered on a patient by patient basis and will require company, Institutional Review Board/Independent Ethics Committee and Single Patient IND approval.

Sex

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria